Report suggests allopurinol may lower blood pressure in teens with hypertension

August 27, 2008

The drug allopurinol, which lowers uric acid levels, appears to reduce blood pressure in adolescents with newly diagnosed hypertension, according to a preliminary report in the August 27 issue of JAMA.

Hypertension is commonly associated with hyperuricemia (elevated blood level of uric acid, a by-product of normal chemical processes in the body and found in the urine and blood). Early research suggested uric acid had a causal role in hypertension, but an elevation of uric acid in hypertension could be a consequence of several factors, and hyperuricemia is not considered a true risk factor for hypertension, according to background information in the article. Recent studies have challenged this belief, including evidence supporting a causal role of uric acid in hypertension, as indicated from experimental studies in laboratory animals.

Daniel I. Feig, M.D., Ph.D., of the Baylor College of Medicine, Houston, and colleagues conducted a randomized, placebo-controlled "crossover" trial to determine whether lowering uric acid levels with the drug allopurinol would reduce blood pressure (BP) in hyperuricemic adolescents (age 11-17 years) with newly diagnosed hypertension. Thirty patients were randomly assigned to receive either allopurinol or placebo, twice daily for four weeks. This was followed by a two week "washout" period during which the patients received neither allopurinol nor placebo, after which they received the other therapy (allopurinol or placebo) they had not received earlier, for four more weeks.

Allopurinol treatment was associated with a significant decrease in casual and ambulatory systolic and diastolic BP. The average decrease in casual BP during allopurinol treatment was −6.9 mm Hg for systolic and −5.1 mm Hg for diastolic BP; for placebo, the respective changes were −2.0 and −2.4. The average changes in 24-hour ambulatory BP during allopurinol were −6.3 mm Hg, systolic; −4.6, diastolic BP. Systolic BP increased slightly during the placebo phase by 0.8 mm Hg and diastolic BP slightly decreased by 0.3. The decrease in ambulatory BP directly correlated with allopurinol treatment. Twenty of the 30 participants achieved normal BP by casual and ambulatory criteria during the allopurinol phase, whereas only 1 of 30 achieved normal BP during the placebo phase.

"The results of this study represent a potentially new therapeutic approach, that of control of a biochemical cause of hypertension, rather than nonspecifically lowering elevated BP. Although not representing a fully developed therapeutic strategy, this study raises an alternative strategy that may prove to be more effective than currently available options," the authors write.

"Despite these findings, this clinical trial is a small one and allopurinol is not indicated for the treatment of hypertension in adolescents or other populations. The potential adverse effects of allopurinol, including gastrointestinal complaints and especially Stevens-Johnson syndrome [a severe, allergic reaction], make allopurinol an unattractive alternative to available antihypertensive medications. More clinical trials are needed to determine the reproducibility of the data and whether it can be generalized to the larger hypertensive population. Nevertheless, the observation that lowering uric acid can reduce BP in adolescents with newly diagnosed hypertension raises intriguing questions about its role in the pathogenesis of hypertension," the researchers conclude.

JAMA and Archives Journals

---

---

	Allopurinol: Webster's Timeline History, 1962 - 2007 by Icon Group International (Author) Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Allopurinol," including when used in literature (e.g. all authors that might have Allopurinol in their name). As such, this book represents the largest compilation of timeline events associated with Allopurinol when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social...
	Allopurinol - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References - SECOND EDITION by Icon Group International (Author) This is a 3-in-1 reference book. It gives a complete medical dictionary covering hundreds of terms and expressions relating to allopurinol. It also gives extensive lists of bibliographic citations. Finally, it provides information to users on how to update their knowledge using various Internet resources. The book is designed for physicians, medical students preparing for Board examinations, medical researchers, and patients who want to become familiar with research dedicated to allopurinol. If your time is valuable, this book is for you. First, you will not waste time searching the Internet while missing a lot of relevant information. Second, the book also saves you time indexing and defining entries. Finally, you will not waste time and money printing hundreds of web pages.
	Allopurinol - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References by ICON Health Publications (Author) This is a 3-in-1 reference book. It gives a complete medical dictionary covering hundreds of terms and expressions relating to allopurinol. It also gives extensive lists of bibliographic citations. Finally, it provides information to users on how to update their knowledge using various Internet resources. The book is designed for physicians, medical students preparing for Board examinations, medical researchers, and patients who want to become familiar with research dedicated to allopurinol. If your time is valuable, this book is for you. First, you will not waste time searching the Internet while missing a lot of relevant information. Second, the book also saves you time indexing and defining entries. Finally, you will not waste time and money printing hundreds of web pages.
	Allopurinol doesn't work? Here's how to lower urate.(Musculoskeletal Disorders): An article from: Family Practice News by Bruce Jancin (Author) This digital document is an article from Family Practice News, published by Thomson Gale on January 15, 2006. The length of the article is 537 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Allopurinol doesn't work? Here's how to lower urate.(Musculoskeletal Disorders) Author: Bruce Jancin Publication: Family Practice News (Magazine/Journal) Date: January 15, 2006 Publisher: Thomson Gale Volume: 36 Issue: 2 Page: 66(1) Distributed by Thomson...
	Gale Encyclopedia of Cancer: Allopurinol by Pharm.D. Olga Bessmertny (Author) The article is excerpted from Gale Encyclopedia of Cancer The resource students and researchers will turn to for reliable, up-to-date and clearly written information, the Gale Encyclopedia of Cancer is a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic procedures. The Encyclopedia includes entries covering cancers, cancer drugs, treatments, side effects and diagnostic procedures. Entries typically include the following elements: Causes and Symptoms Definition Description Diagnosis Prevention Resources Risks Special Concerns And more An appendix provides complete contact information for cancer centers, national support groups, government agencies and research groups. Features include anatomical...
	Allopurinol: An entry from Thomson Gale's Gale Encyclopedia of Cancer, 2nd ed. by Olga, Pharm.D. Bessmertny (Author) Students, researchers, and patients can find reliable, up-to-date and clearly written information in “The Gale Encyclopedia of Cancer,” a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic procedures.
	New agents for gout provide alternatives to allopurinol.(RHEUMATOLOY): An article from: Internal Medicine News by Nancy Walsh (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2009. The length of the article is 788 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: New agents for gout provide alternatives to allopurinol.(RHEUMATOLOY) Author: Nancy Walsh Publication: Internal Medicine News (Magazine/Journal) Date: January 15, 2009 Publisher: International Medical News Group Volume: 42 Issue: 2 Page: 13(1) Distributed by Gale, a part of Cengage...
	Febuxostat, allopurinol jockey for role in gout.(MUSCULOSKELETAL DISORDERS): An article from: Family Practice News by Mitchel L. Zoler (Author) This digital document is an article from Family Practice News, published by International Medical News Group on October 1, 2009. The length of the article is 1440 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Febuxostat, allopurinol jockey for role in gout.(MUSCULOSKELETAL DISORDERS) Author: Mitchel L. Zoler Publication: Family Practice News (Magazine/Journal) Date: October 1, 2009 Publisher: International Medical News Group Volume: 39 Issue: 17 Page: 30(2) Distributed by Gale, a part of Cengage...
	Allopurinol aids patients with stable angina.(CARDIOVASCULAR MEDICINE)(Clinical report): An article from: Family Practice News by Mitchel L. Zoler (Author) This digital document is an article from Family Practice News, published by International Medical News Group on October 15, 2009. The length of the article is 527 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Allopurinol aids patients with stable angina.(CARDIOVASCULAR MEDICINE)(Clinical report) Author: Mitchel L. Zoler Publication: Family Practice News (Magazine/Journal) Date: October 15, 2009 Publisher: International Medical News Group Volume: 39 Issue: 18 Page: 18(1) Article Type: Clinical report Distributed by Gale, a part of Cengage...
	Febuxostat or allopurinol for gout? It depends.(RHEUMATOLOGY): An article from: Internal Medicine News by Mitchel L. Zoler (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on December 1, 2009. The length of the article is 1280 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Febuxostat or allopurinol for gout? It depends.(RHEUMATOLOGY) Author: Mitchel L. Zoler Publication: Internal Medicine News (Magazine/Journal) Date: December 1, 2009 Publisher: International Medical News Group Volume: 42 Issue: 21 Page: 75(1) Distributed by Gale, a part of Cengage...